Ribosomal s6 kinase is a mediator of aquaporin-2 S256 phosphorylation and membrane accumulation after EGFR inhibition with erlotinib | ||
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigación en Biomedicina de Buenos Aires - Instituto Partner de la Sociedad Max Planck | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.contributor.author | Babicz, Richard S. E. | |
| dc.contributor.author | Baylor, Noah | |
| dc.contributor.author | Terlouw, Abby | |
| dc.contributor.author | Faber, Daphne A. | |
| dc.contributor.author | Fukushima, Kazuhiko | |
| dc.contributor.author | Biondi, Ricardo Miguel | |
| dc.contributor.author | Bouley, Richard | |
| dc.contributor.author | Brown, Dennis | |
| dc.date.issued | 2025-03 | |
| dc.description.abstract | Vasopressin (VP) activates protein kinase A (PKA), resulting in phosphorylation events and membrane accumulation of aquaporin-2 (AQP2). Epidermal growth factor receptor (EGFR) inhibition with erlotinib also induces AQP2 membrane trafficking with a phosphorylation pattern similar to VP, but without increasing PKA activity. Here, we identify the ribosomal s6 kinase (RSK) as a major mediator phosphorylating AQP2 in this novel, erlotinib-induced pathway. We found that RSK was expressed in collecting duct principal cells in rat kidneys. RSK inhibition with BI-D1870 blocked erlotinib-induced AQP2 serine 256 (S256) phosphorylation and membrane accumulation. CRISPR-generated RSK knockout (KO) cells failed to show increased S256 phosphorylation in response to erlotinib. Like PKA, RSK was able to phosphorylate AQP2 S256 in vitro. Inhibition of phosphoinositide-dependent kinase-1 (PDK1), a known activator of RSK, blocked erlotinib-induced AQP2 S256 phosphorylation and membrane accumulation. We conclude that RSK is a crucial terminal kinase phosphorylating AQP2 at S256 upon EGFR inhibition by erlotinib.NEW & NOTEWORTHY Epidermal growth factor receptor (EGFR) inhibition with erlotinib induces aquaporin-2 (AQP2) membrane accumulation with a phosphorylation pattern similar to vasopressin (VP). Here, we identify the ribosomal s6 kinase (RSK) as a major mediator phosphorylating AQP2 in this novel, erlotinib-induced pathway. In addition, we show that phosphoinositide-dependent kinase-1 (PDK1), a known activator of RSK, is implicated in this pathway: PDK1 inhibition blocks erlotinib-induced AQP2 S256 phosphorylation and membrane accumulation. | es |
| dc.description.fil | Fil: Babicz, Richard S. E.. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Baylor, Noah. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Terlouw, Abby. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Faber, Daphne A.. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Fukushima, Kazuhiko. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Biondi, Ricardo Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigación en Biomedicina de Buenos Aires - Instituto Partner de la Sociedad Max Planck; Argentina | |
| dc.description.fil | Fil: Bouley, Richard. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Brown, Dennis. Harvard Medical School; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Babicz, Richard S. E.; Baylor, Noah; Terlouw, Abby; Faber, Daphne A.; Fukushima, Kazuhiko; et al.; Ribosomal s6 kinase is a mediator of aquaporin-2 S256 phosphorylation and membrane accumulation after EGFR inhibition with erlotinib; American Physiological Society; American Journal Of Physiology-renal Physiology; 328; 3; 3-2025; F344-F359 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1931-857X | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/289186 | |
| dc.journal.ciudad | Bethesda | es |
| dc.journal.number | 3 | es |
| dc.journal.pagination | F344-F359 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | American Journal Of Physiology-renal Physiology | es |
| dc.journal.volume | 328 | es |
| dc.language.iso | eng | es |
| dc.publisher | American Physiological Society | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://journals.physiology.org/doi/10.1152/ajprenal.00353.2024 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1152/ajprenal.00353.2024 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | PDK1 | es |
| dc.subject | Allosteric | es |
| dc.subject | S6K | es |
| dc.subject | EGFR | es |
| dc.subject.classification | Bioquímica y Biología Molecular | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Ribosomal s6 kinase is a mediator of aquaporin-2 S256 phosphorylation and membrane accumulation after EGFR inhibition with erlotinib | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.79d1489a-d20d-4fa4-a560-d20de1c14f5f_B.pdf
- Tamaño:
- 6.4 MB
- Formato:
- Adobe Portable Document Format